डॉ. नीतीश शर्मा, पीएच.डी.
सहायक प्रोफेसर , औषध विश्लेषण विभाग
अनुसंधान हित
Extensive characterization of complex injectable products for facilitating generics development, Impurity profiling of drug product, Synthetic peptide characterization, drug-excipient interaction degradation products.
Experience
-
April 2021 -Present
Assistant Professor
NIPER Ahmedabad, Gujarat, India
-
June 2013 - April 2021
Senior Manager
Analytical Research & Development in Sun Pharmaceutical Industries Limited (India)
-
Feb 2006 - June 2013
Scientist
Analytical research- US-Europe market R&D, Dr. Reddys Laboratories Ltd, Hyderabad
Publications
- A Novel Validated Stability Indicating HPLC Method for Estimation of Degradation behavior of Eberconazole nitrate and Mometasone furoate in cream formulation. (Indian Journal of Pharmaceutical Science 2013; 75(1):76-82).
- Optimization and Validation of Reverse Phase Liquid Chromatographic Method for Estimation of Cetirizine Mannitol Ester Impurity in Cetirizine Hydrochloride Chewable Tablet. Journal of Liquid Chromatography & Related Technologies.(DOI: 10.1080/10826076.2011.585485)
- A Novel Validated Ultra High Pressure Liquid Chromatography Method for Separation of Eszopiclone impurities and its degradent in drug product. (Schedule to publish in September-October 2013 issue in journal of AOAC International).
- A novel and rapid validated stability indicating UPLC method of related substances for Dorzolamide Hydrochloride and Timolol Maleate in Ophthalmic Dosage form. Journal of Chromatographic Science (DOI: 10.1093/chromsci/bms025)
- A Validated Stability-Indicating Liquid-Chromatographic Method for Ranitidine Hydrochloride in Liquid Oral Dosage Form. Scientia Pharmaceutica [DOI: 10.3797/scipharm.1101-06]
- A Novel Validated High Pressure Liquid Chromatography Method for Separation of Pioglitazone degradent in drug product. International Journal of Pharmacy and Pharmaceutical Sciences (Volume 4, Supplement 1, 2012).
- A validated ultra high-pressure liquid chromatography method for separation of Candesartan Cilexetil impurities and its degradents in drug product. Pharmaceutical Methods (DOI: 10.4103-2229-4708.97718).